Characterization and quantification of alcohol-related polyneuropathy by magnetic resonance neurography.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
02 2022
Historique:
revised: 06 09 2021
received: 20 04 2021
accepted: 22 09 2021
pubmed: 27 9 2021
medline: 5 4 2022
entrez: 26 9 2021
Statut: ppublish

Résumé

We characterized and quantified peripheral nerve damage in alcohol-dependent patients (ADP) by magnetic resonance neurography (MRN) in correlation with clinical and electrophysiologic findings. Thirty-one adult patients with a history of excessive alcohol consumption and age-/sex-matched healthy controls were prospectively examined. After detailed neurologic and electrophysiologic testing, the patient group was subdivided into ADP with alcohol-related polyneuropathy (ALN) and without ALN (Non-ALN). 3T MRN with anatomical coverage from the proximal thigh down to the tibiotalar joint was performed using dual-echo 2-dimensional relaxometry sequences with spectral fat saturation. Detailed quantification of nerve injury by morphometric (cross-sectional area [CSA]) and microstructural MRN markers (proton spin density [ρ], apparent T2-relaxation-time [T2 MRN detected nerve damage in ADP with and without ALN. A proximal-to-distal gradient was identified for nerve T2-weighted (T2w)-signal and T2 MRN detects and quantifies peripheral nerve damage in ADP in vivo even in the absence of clinically overt ALN. Microstructural markers (T2

Sections du résumé

BACKGROUND
We characterized and quantified peripheral nerve damage in alcohol-dependent patients (ADP) by magnetic resonance neurography (MRN) in correlation with clinical and electrophysiologic findings.
METHODS
Thirty-one adult patients with a history of excessive alcohol consumption and age-/sex-matched healthy controls were prospectively examined. After detailed neurologic and electrophysiologic testing, the patient group was subdivided into ADP with alcohol-related polyneuropathy (ALN) and without ALN (Non-ALN). 3T MRN with anatomical coverage from the proximal thigh down to the tibiotalar joint was performed using dual-echo 2-dimensional relaxometry sequences with spectral fat saturation. Detailed quantification of nerve injury by morphometric (cross-sectional area [CSA]) and microstructural MRN markers (proton spin density [ρ], apparent T2-relaxation-time [T2
RESULTS
MRN detected nerve damage in ADP with and without ALN. A proximal-to-distal gradient was identified for nerve T2-weighted (T2w)-signal and T2
CONCLUSIONS
MRN detects and quantifies peripheral nerve damage in ADP in vivo even in the absence of clinically overt ALN. Microstructural markers (T2

Identifiants

pubmed: 34564924
doi: 10.1111/ene.15127
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

573-582

Informations de copyright

© 2021 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.

Références

Chopra K, Tiwari V. Alcoholic neuropathy: possible mechanisms and future treatment possibilities. Br J Clin Pharmacol. 2012;73:348-362.
Sobue G, Koike H. Alcoholic neuropathy. Med J Aust. 1982;2:274-275.
Koike H, Sobue G. Alcoholic neuropathy. Curr Opin Neurol. 2006;19:481-486.
Koike H, Mori K, Misu K, et al. Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology. 2001;56:1727-1732.
Thompson PD, Thomas PK. Clinical patterns of peripheral neuropathy. In: Dyck P, Thomas PK, eds. Peripheral Neuropathy. 4th ed. Elsevier, Saunders; 2005:1137-1161.
Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol. 1981;10:222-226.
Bendszus M, Stoll G. Technology insight: visualizing peripheral nerve injury using MRI. Nat Clin Pract Neurol. 2005;1:45-53.
Pham M, Baumer P, Meinck H-M, et al. Anterior interosseous nerve syndrome: fascicular motor lesions of median nerve trunk. Neurology. 2014;82:598-606.
Jende JME, Groener JB, Oikonomou D, et al. Diabetic neuropathy differs between type 1 and type 2 diabetes: insights from magnetic resonance neurography. Ann Neurol. 2018;83:588-598.
Kollmer J, Hilgenfeld T, Ziegler A, et al. Quantitative MR neurography biomarkers in 5q-linked spinal muscular atrophy. Neurology. 2019;93:e653-e664.
Kollmer J, Hund E, Hornung B, et al. In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography. Brain. 2015;138:549-562.
Kollmer J, Sahm F, Hegenbart U, et al. Sural nerve injury in familial amyloid polyneuropathy MR neurography vs clinicopathologic tools. Neurology. 2017;89:475-484.
Shahani BT, Halperin JJ, Boulu P, Cohen J. Sympathetic skin response - a method of assessing unmyelinated axon dysfunction in peripheral neuropathies. J Neurol Neurosurg Psychiatry. 1984;47:536-542.
Jenkinson M, Beckmann CF, Behrens TEJ, et al. Review FSL. NeuroImage. 2012;62:782-790.
Pham M, Oikonomou D, Hornung B, et al. Magnetic resonance neurography detects diabetic neuropathy early and with proximal predominance. Ann Neurol. 2015;78:939-948.
Heiland S, Sartor K, Martin E, et al. In vivo monitoring of age-related changes in rat brain using quantitative diffusion magnetic resonance imaging and magnetic resonance relaxometry. Neurosci Lett. 2002;334:157-160.
Miot E, Hoffschir D, Alapetite C, et al. Experimental MR study of cerebral radiation injury: quantitative T2 changes over time and histopathologic correlation. Am J Neuroradiol. 1995;16:79-85.
Walimuni IS, Hasan KM. Atlas-based investigation of human brain tissue microstructural spatial heterogeneity and interplay between transverse relaxation time and radial diffusivity. NeuroImage. 2011;57:1402-1410.
Kollmer J, Weiler M, Purrucker J, et al. MR neurography biomarkers to characterize peripheral neuropathy in AL amyloidosis. Neurology. 2018;91:e625-e634.
Jende JME, Hauck GH, Diem R, et al. Peripheral nerve involvement in multiple sclerosis: demonstration by magnetic resonance neurography. Ann Neurol. 2017;82:676-685.
Nijeholt GJ, Bergers E, Kamphorst W, et al. Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype. Brain. 2001;124:154-166.
Kucera P, Balaz M, Varsik P, Kurca E. Pathogenesis of alcoholic neuropathy. Bratisl Lek Listy. 2002;103:26-29.
Victor M, Adams RD. On the etiology of the alcoholic neurologic diseases with special reference to the role of nutrition. Am J Clin Nutr. 1961;9:379-397.
Mellion ML, Nguyen V, Tong M, et al. Experimental model of alcohol-related peripheral neuropathy. Muscle Nerve. 2013;48:204-211.
Hammoud N, Jimenez-Shahed J. Chronic neurologic effects of alcohol. Clin Liver Dis. 2019;23:141-155.
Sadowski A, Houck RC. Alcoholic neuropathy. Treasure Island, FL: StatPearls Publishing, 2021.
García-Valdecasas-Campelo E, González-Reimers E, Santolaria-Fernández F, et al. Brain atrophy in alcoholics: relationship with alcohol intake; liver disease; nutritional status, and inflammation. Alcohol Alcohol. 2007;42:533-538.
Nicolás JM, Fernández-Solà J, Robert J, et al. High ethanol intake and malnutrition in alcoholic cerebellar shrinkage. QJM - Mon J Assoc Physicians. 2000;93:449-456.

Auteurs

Christian Rother (C)

Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.

Jan Malte Bumb (JM)

Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.

Markus Weiler (M)

Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.

Anna Brault (A)

Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.

Georges Sam (G)

Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.

John M Hayes (JM)

Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.

Adriana Pietsch (A)

Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Department of Internal Medicine, Spital Walenstadt, Walenstadt, Switzerland.

Kianush Karimian-Jazi (K)

Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.

Johann M E Jende (JME)

Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.

Sabine Heiland (S)

Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Division of Experimental Radiology, Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.

Falk Kiefer (F)

Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.

Martin Bendszus (M)

Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.

Jennifer Kollmer (J)

Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH